Correlation Between Salesforce and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Salesforce and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and ABVC Biopharma, you can compare the effects of market volatilities on Salesforce and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and ABVC Biopharma.
Diversification Opportunities for Salesforce and ABVC Biopharma
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Salesforce and ABVC is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Salesforce i.e., Salesforce and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Salesforce and ABVC Biopharma
Considering the 90-day investment horizon Salesforce is expected to generate 98.93 times less return on investment than ABVC Biopharma. But when comparing it to its historical volatility, Salesforce is 7.2 times less risky than ABVC Biopharma. It trades about 0.02 of its potential returns per unit of risk. ABVC Biopharma is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 106.00 in ABVC Biopharma on April 30, 2025 and sell it today you would earn a total of 196.00 from holding ABVC Biopharma or generate 184.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Salesforce vs. ABVC Biopharma
Performance |
Timeline |
Salesforce |
ABVC Biopharma |
Salesforce and ABVC Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Salesforce and ABVC Biopharma
The main advantage of trading using opposite Salesforce and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify Class A | Salesforce vs. Workday |
ABVC Biopharma vs. RenovoRx | ABVC Biopharma vs. Adial Pharmaceuticals | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |